captopril has been researched along with mocetinostat in 16 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 4 (25.00) | 18.2507 |
| 2000's | 6 (37.50) | 29.6817 |
| 2010's | 5 (31.25) | 24.3611 |
| 2020's | 1 (6.25) | 2.80 |
| Authors | Studies |
|---|---|
| Dranchak, PK; Huang, R; Inglese, J; Lamy, L; Oliphant, E; Queme, B; Tao, D; Wang, Y; Xia, M | 1 |
| Grøn, B; Iversen, L; Kragballe, K; Kristensen, P; Ziboh, VA | 1 |
| Miselis, J; Siminiak, T; Wysocki, H | 1 |
| Battler, A; Hasdai, D; Leor, J; Ovadia, Z; Varda-Bloom, N | 1 |
| Gutiérrez Correa, J; Stoppani, AO | 1 |
| Fischer, S; Kalirai, B; Keshavjee, S; Liu, M; Maclean, AA | 1 |
| Barros, LF; Becker, C; Carvalho, MH; de Gusmão, FM | 1 |
| Alican, I; Ercan, F; Gedik, N; Jahovic, N; Sener, G; Yüksel, M | 1 |
| Babar, S; Boudjeltia, KZ; Ducobu, J; Legssyer, I; Moguilevsky, N; Moreau, P; Nève, J; Van Antwerpen, P; Vanhaeverbeek, M | 1 |
| Dem'iankova, IuO; Kratnov, AA; Kratnov, AE; Popov, SA | 1 |
| Babar, S; Ducobu, J; Legssyer, I; Moguilevsky, N; Moreau, P; Nève, J; Van Antwerpen, P; Vanhaeverbeek, M; Zouaoui Boudjeltia, K | 1 |
| Celik, HA; Ilter, T; Nart, D; Oruc, N; Ozutemiz, O; Yuce, G | 1 |
| Gemici, B; Izgüt-Uysal, VN; Ongüt, G; Tan, R | 1 |
| Chen, X; Ji, ZZ; Li, SL; Wu, T; Zhang, XW | 1 |
| Laraba-Djebari, F; Martin-Eauclaire, MF; Medjadba, W | 1 |
| El-Ashmawy, NE; El-Bahrawy, HA; Hamada, OB; Khedr, NF | 1 |
1 trial(s) available for captopril and mocetinostat
| Article | Year |
|---|---|
[Lisinopril-induced changes in antioxidant defense in patients with acute coronary syndrome and concomitant diabetes mellitus type 2].
Topics: Angiotensin-Converting Enzyme Inhibitors; Biomarkers; Captopril; Catalase; Diabetes Mellitus, Type 2; Disease Progression; Female; Follow-Up Studies; Glutathione Reductase; Humans; Lisinopril; Male; Middle Aged; Myocardial Ischemia; Neutrophils; Oxidative Stress; Oxidoreductases; Peroxidase; Severity of Illness Index; Spectrophotometry; Superoxide Dismutase; Treatment Outcome | 2005 |
15 other study(ies) available for captopril and mocetinostat
| Article | Year |
|---|---|
In vivo quantitative high-throughput screening for drug discovery and comparative toxicology.
Topics: Animals; Caenorhabditis elegans; Drug Discovery; High-Throughput Screening Assays; Humans; Proteomics; Small Molecule Libraries | 2023 |
Human epidermis transforms exogenous leukotriene A4 into peptide leukotrienes: possible role in transcellular metabolism.
Topics: Biotransformation; Captopril; Chromatography, High Pressure Liquid; Epidermis; Ethacrynic Acid; gamma-Glutamyltransferase; Humans; Keratinocytes; Leucine; Leukotriene A4; Leukotriene B4; Leukotriene C4; Leukotrienes; Neutrophils; Peroxidase | 1994 |
Evidence for stimulation of neutrophil degranulation by selected angiotensin converting enzyme inhibitors in vitro.
Topics: Adult; Angiotensin-Converting Enzyme Inhibitors; Captopril; Cell Degranulation; Enalaprilat; Female; Humans; In Vitro Techniques; Lisinopril; Male; Middle Aged; Muramidase; Neutrophils; Peroxidase; Ramipril; Spectrophotometry; Zymosan | 1994 |
Failure of captopril to attenuate myocardial damage, neutrophil accumulation, and mortality following coronary artery occlusion and reperfusion in rat.
Topics: Animals; Blood Pressure; Captopril; Creatine Kinase; Male; Myocardial Infarction; Myocardial Reperfusion Injury; Myocardium; Neutrophils; Peroxidase; Rats; Rats, Sprague-Dawley; Time Factors | 1994 |
[Myeloperoxidase as a factor of oxidative damage of the myocardium: inactivation of dihydrolipoamide dehydrogenase].
Topics: Acetaminophen; Animals; Captopril; Dihydrolipoamide Dehydrogenase; Free Radicals; Myocardial Reperfusion Injury; Myocardium; Oxidants; Peroxidase; Swine; Time Factors | 1998 |
Inhibition of angiotensin-converting enzyme by captopril: a novel approach to reduce ischemia-reperfusion injury after lung transplantation.
Topics: Angiotensin-Converting Enzyme Inhibitors; Animals; Blood Pressure; Captopril; Dextrans; Dinoprost; F2-Isoprostanes; Free Radical Scavengers; Glucose; Lung; Lung Transplantation; Male; Neutrophil Activation; Organ Preservation; Oxygen; Peroxidase; Rats; Rats, Inbred Lew; Reperfusion Injury; Systole | 2000 |
Angiotensin II inhibition during myocardial ischemia-reperfusion in dogs: effects on leukocyte infiltration, nitric oxide synthase isoenzymes activity and left ventricular ejection fraction.
Topics: Angiotensin-Converting Enzyme Inhibitors; Animals; Captopril; Dogs; Hemodynamics; Losartan; Myocardial Reperfusion; Myocardial Reperfusion Injury; Myocardium; Nitric Oxide Synthase; Peroxidase; Stroke Volume | 2005 |
The effect of angiotensin-converting enzyme inhibitors on experimental colitis in rats.
Topics: Angiotensin-Converting Enzyme Inhibitors; Animals; Captopril; Colitis; Collagen; Colon; Disease Models, Animal; Enzyme Inhibitors; Female; Glutathione; Lisinopril; Male; Malondialdehyde; Organ Size; Peroxidase; Rats; Rats, Sprague-Dawley; Reactive Oxygen Species; Time Factors; Trinitrobenzenesulfonic Acid; Tumor Necrosis Factor-alpha | 2005 |
Thiol-containing molecules interact with the myeloperoxidase/H2O2/chloride system to inhibit LDL oxidation.
Topics: Acetylcysteine; Antioxidants; Captopril; Chlorides; Flufenamic Acid; Glutathione; Hydrogen Peroxide; Lipoproteins, LDL; Lysine; Oxidation-Reduction; Peroxidase; Sulfhydryl Compounds | 2005 |
Captopril inhibits the oxidative modification of apolipoprotein B-100 caused by myeloperoxydase in a comparative in vitro assay of angiotensin converting enzyme inhibitors.
Topics: Angiotensin-Converting Enzyme Inhibitors; Antihypertensive Agents; Apolipoprotein B-100; Apolipoproteins B; Atherosclerosis; Captopril; Enalapril; Fosinopril; Humans; Hydrogen Peroxide; Hypochlorous Acid; Lipoproteins, LDL; Lisinopril; Oxidation-Reduction; Peroxidase; Ramipril; Recombinant Proteins | 2006 |
Inhibition of renin-angiotensin system in experimental acute pancreatitis in rats: a new therapeutic target?
Topics: Amylases; Angiotensin II Type 1 Receptor Blockers; Angiotensin-Converting Enzyme Inhibitors; Animals; Captopril; Ceruletide; Disease Models, Animal; Imidazoles; Injections, Intraperitoneal; Male; Neutrophil Infiltration; Pancreas; Pancreatitis, Acute Necrotizing; Peroxidase; Rats; Rats, Wistar; Renin-Angiotensin System; Taurocholic Acid; Tetrazoles; Treatment Outcome | 2010 |
Expressions of inducible nitric oxide synthase and cyclooxygenase-2 in gastric ischemia-reperfusion: role of angiotensin II.
Topics: Angiotensin II; Angiotensin II Type 1 Receptor Blockers; Angiotensin II Type 2 Receptor Blockers; Angiotensin-Converting Enzyme Inhibitors; Animals; Benzimidazoles; Biphenyl Compounds; Captopril; Cyclooxygenase 2; Dinoprostone; Gastritis; Imidazoles; Male; Neutrophils; Nitric Oxide; Nitric Oxide Synthase Type II; Peroxidase; Pyridines; Rats; Rats, Wistar; Reperfusion Injury; Tetrazoles | 2010 |
[Protective effects of captopril against lung injury in rats with severe acute pancreatitis].
Topics: Amylases; Angiotensin II; Animals; Captopril; Disease Models, Animal; Lung; Lung Injury; Male; Pancreatitis; Peroxidase; Rats; Rats, Sprague-Dawley; Tumor Necrosis Factor-alpha | 2010 |
Involvement of Kallikrein-Kinin System on Cardiopulmonary Alterations and Inflammatory Response Induced by Purified Aah I Toxin from Scorpion Venom.
Topics: Angiotensin-Converting Enzyme Inhibitors; Animals; Aprotinin; Bradykinin; Bradykinin B2 Receptor Antagonists; Bronchoalveolar Lavage Fluid; Capillary Permeability; Captopril; Cytokines; Eosinophil Peroxidase; Kallikreins; Leukocyte Count; Male; Peroxidase; Pulmonary Edema; Rats; Rats, Wistar; Scorpion Venoms | 2016 |
Anti-inflammatory and Antioxidant Effects of Captopril Compared to Methylprednisolone in L-Arginine-Induced Acute Pancreatitis.
Topics: Acute Disease; alpha-Amylases; Angiotensin-Converting Enzyme Inhibitors; Animals; Anti-Inflammatory Agents; Antioxidants; Arginine; Captopril; Cytoprotection; Disease Models, Animal; Glutathione; Lipase; Male; Methylprednisolone; Nitric Oxide; Nitric Oxide Synthase Type II; Pancreas; Pancreatitis; Peroxidase; Rats, Wistar; Renin-Angiotensin System; Signal Transduction; Tumor Necrosis Factor-alpha | 2018 |